Dr J Vijay Venkatraman to chair the 3rd Indian Pharmacovigilance Day Conference
The conference will be held at Hotel Kohinoor Continental on July 27,2018
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Dr Partap Chauhan honoured with ‘Lifetime Achievement Award’ for work in Ayurveda
Ayurvedacharya Dr Partap Chauhan was awarded at an Arogyam Conclave and Awards Ceremony in the presence of Shripad Naik, Minister…
Dr. Reddy launches Esomeprazole Magnesium Delayed-Release Capsules US market
The capsule treats frequent heartburn occurring two or more days a week in adults
Neelanjan Banerjee, new MD for LANXESS, India
He joined LANXESS in 2006 as head of the former Basic Chemicals business unit and the Saltigo business unit in India
Lupin gets tentative FDA approval for Tadalafil tablets
The company will market a generic version of Eli Lilly and Company’s Cialis tablets
EU and Japan reinforce their collaboration on inspections of medicine manufacturers
The European Union (EU) and Japan have agreed to broaden the range of medicines for which they will recognise each other’s…
US FDA approves Sun Pharma’s INFUGEM Injection
It is the first US FDA approval for a product from the Halol facility post receipt of EIR
Ahmedabad University, University of California San Diego launches global executive MBA programme for…
The two-year programme for working executives, with 27 tailored courses, will begin from September 2018
UIPS research scholar granted commonwealth scholarship for UK
The grant will help to carry out interdisciplinary Indo-British collaborative research in domain of novel nanostructured drug…
US FDA gives nod to Zydus for acne treatment topical solution
The company will manufacture the product at the group's topical manufacturing facility in Ahmedabad
Glenmark receives ANDA approval for Colesevelam Hydrochloride
The US FDA grants final ANDA approval for generic version of Welchol for oral suspension
Cipla agrees to buy South African pharma maker for INR 225 cr
Cipla said it has agreed to buy South African pharmaceuticals maker Mirren for 450 mln rand, or about INR 225 cr.
Drug regulator orders recall of Novartis’s painkiller diclofenac
Drug controller general of India (DCGI ) cancels licence for diclofenac sold by Novartis after concerns raised by a health…
DRL to appeal against US court decision
The US court barred DRL from sales and commercialisation of Buprenorphine and Naloxone Sublingual Film
Delhi hosts third edition of Healthcare Senate
Leaders and game changers in India’s private healthcare sector came together at the event organised by Express Healthcare and The…
Lupin receives FDA approval for Nitrofurantoin capsules
Lupin receives FDA approval for Nitrofurantoin capsules
Zydus Hospira receives EIR for Ahmedabad facility
US FDA audited the manufacturing plant from April 5 - 12, 2018
Alembic receives US FDA tentative approval for Ticagrelor Tablets, 90 mg
Ticagrelor tablets are indicated to reduce the rate of cardiovascular death, myocardial infarction, and stroke in patients with…
Cipla Medpro strengthens footprint in South Africa
The company plans to grow by acquiring 100 per cent stake in Mirren